- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | AAV-Optimised Linear PEI Transfection Reagent for Suspension 293 Platforms |
| Catalog No. | RERE-0100 |
| Description | Developed specifically for scalable AAV production in suspension culture, this optimised linear polyethylenimine reagent is produced by pure chemical synthesis without animal derived components and supplied as a sterile liquid. It carries strong DNA loading capacity, low transfection complex ratio with complex volume down to 1%, high complex stability and roughly half the reagent dosage, lowering cost. Broad AAV serotype compatibility covers AAV2, AAV5, AAV8 and AAV9 among others, with a high full-to-empty particle ratio supporting large scale AAV manufacturing. GMP production and a drug master file filing are in place. |
| Intended Use | Scalable AAV viral vector production in suspension 293 cell platforms; gene therapy vector manufacturing |
| Principle / Technology | Polycation mediated plasmid delivery optimised for high-density suspension AAV packaging |
| Sample Type | Suspension 293 cell lines such as 293F |
| Storage Conditions | 2 to 8°C |
| Shelf Life | 2 years |
| Package Specifications | 100 uL; 1 mL; 10 mL; 100 mL |
| Product Form | Sterile liquid |
| Key Features | Strong DNA loading; complex volume down to 1%; high complex stability; about half reagent dosage; broad serotype compatibility; GMP production with drug master file filed |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
